Regentis Biomaterials Ltd. Withdrawal of Registration Statement

Regentis Biomaterials Ltd. has filed a request to withdraw its Registration Statement on Form F-1 (File No. 333-295510), which was to be effective on June 15, 2026. The company has decided not to proceed with the public offering that the Registration Statement was related to. This decision was formally communicated to the Securities and Exchange Commission on June 15, 2026. The filing indicates that the company will continue to file its annual reports under Form 20-F.